GERMANY - JenaValve raises an additional EUR 10m

Existing investor Atlas Venture was also a significant participant in this round, which was complemented by an additional new investor, NeoMed.

So far the company has raised a total of EUR 13.5m. The capital will support product finalisation, patent and marketing activities, pre-clinical and clinical trials and serial production.

JenaValve™ Technology is a medical device company specialised in developing minimally-invasive heart valve replacement systems.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Early-stage
• DACH